What is the Sarepta Therapeutics Inc. stock price forecast?

Sarepta Therapeutics Inc. is currently trading at $15.31. View real-time AI analysis on Alpha Lenz.

What is Sarepta Therapeutics Inc. insider trading activity?

View the latest insider trading data for Sarepta Therapeutics Inc. on Alpha Lenz.

What is Sarepta Therapeutics Inc.'s P/E ratio?

Sarepta Therapeutics Inc.'s P/E ratio is -2.1.

Sarepta Therapeutics Inc.

NASDAQ · SRPT

$15.31+0.31(+2.07%)Pre-market

Ask about Sarepta Therapeutics Inc.'s future dividend policy...

Alpha Chat Insight

“Sarepta Therapeutics Inc. trades at a P/E of -2.1 (undervalued) with modest ROE of -53.5%. 3Y revenue CAGR of 33.1% highlights clear growth momentum.”

Ask for details →

Company Overview

SectorUnknown

IndustryUnknown

Company Statistics

FY 2025

Profile

$1.53BMarket Cap

$2.20BRevenue

0.00Shares Out

N/AEmployees

Margins

61.81%Gross

-26.32%EBITDA

-29.92%Operating

-31.94%Pre-Tax

-32.45%Net

Valuation

-2.15P/E

1.34P/B

0.70EV/Sales

-3.06EV/EBITDA

-4.86P/FCF

Growth (CAGR)

33.06%Rev 3Yr

32.41%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-19.51%ROA

-53.47%ROE

-18.16%ROIC

Financial Health

$801.28MCash & Cash Equivalents

$1.41BNet Debt

193.67%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Sarepta Therapeutics Inc. trades at a P/E of -2.1 (undervalued) with modest ROE of -53.5%. 3Y revenue CAGR of 33.1% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Sarepta Therapeutics Inc. (ticker: SRPT) is a company listed on NASDAQ in the Unknown sector (Unknown). Market cap is $1.5B.

The current price is $15.31 with a P/E ratio of -2.15x and P/B of 1.34x.

ROE is -53.47% and operating margin is -29.92%. Annual revenue is $2.2B.